<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药经济报 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-16T21:32:29+08:00</updated>
  <subtitle>《医药经济报》是国家药品监督管理局南方医药经济研究所主办、全国公开发行的专业报刊，1980年创刊，解读全球产经数据，引领主流思维创新。以办中国最好的专业报为宗旨，旨在成为产业的良心和脑袋，为促进公众健康及医药发展提供智库解决方</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>医保谈判第三天：PD-1/L1价格混战！国内企业报价低于4万/年</title>
    <updated>2020-12-16T19:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/dWnra8iryPbiadfIoMZVtA</id>
    <link href="https://mp.weixin.qq.com/s/dWnra8iryPbiadfIoMZVtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南方所与安徽省药监局一行座谈砀山县迈瑞医疗科技产业园规划</title>
    <updated>2020-12-16T19:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/1TRpjWYgg7EVK4ytV84d-A</id>
    <link href="https://mp.weixin.qq.com/s/1TRpjWYgg7EVK4ytV84d-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推进冠脉支架带量集采：科学制度设计保市场稳定，降低患者负担</title>
    <updated>2020-12-16T19:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/kEK_jI1cPMtkwJ1YDS1Jqw</id>
    <link href="https://mp.weixin.qq.com/s/kEK_jI1cPMtkwJ1YDS1Jqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国首个原研PARP抑制剂氟唑帕利获批上市</title>
    <updated>2020-12-16T19:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/XMFg-LpO7IUvnc24yhlqaA</id>
    <link href="https://mp.weixin.qq.com/s/XMFg-LpO7IUvnc24yhlqaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判第二日，涉及肿瘤、眼病、脑部疾病治疗领域，GV-971引关注！</title>
    <updated>2020-12-15T18:42:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/bpQMXTzWHs58x3FsWrdg4A</id>
    <link href="https://mp.weixin.qq.com/s/bpQMXTzWHs58x3FsWrdg4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谈判进医保后，销售额达标了吗？</title>
    <updated>2020-12-15T18:42:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/VqOa90VxMZHWpGtckHa3tg</id>
    <link href="https://mp.weixin.qq.com/s/VqOa90VxMZHWpGtckHa3tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药南方总部及研发中心项目建设正式启动</title>
    <updated>2020-12-15T18:42:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/RX_0yhgY47ckAeAmNcwJHQ</id>
    <link href="https://mp.weixin.qq.com/s/RX_0yhgY47ckAeAmNcwJHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>启动与东莞国药战略合作，宏济堂制药再迎发展新机遇</title>
    <updated>2020-12-15T18:42:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ymvNtTz5PoDxs9hw-N5gUg</id>
    <link href="https://mp.weixin.qq.com/s/ymvNtTz5PoDxs9hw-N5gUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判首日，中成药独家品种降价三成开局！数百品种看点几何？</title>
    <updated>2020-12-14T18:50:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/dVhwlyF4phnXnTNnUvsUpA</id>
    <link href="https://mp.weixin.qq.com/s/dVhwlyF4phnXnTNnUvsUpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判给DTP药房带来哪些机会？</title>
    <updated>2020-12-14T18:50:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/GYhTOcg7dsBx9LKQKHjXIg</id>
    <link href="https://mp.weixin.qq.com/s/GYhTOcg7dsBx9LKQKHjXIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅发布！紫杉醇脂质体+顺铂对比吉西他滨+顺铂一线治疗晚期肺鳞癌结果出炉</title>
    <updated>2020-12-14T18:50:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/LA47_Gtd5TnKxclooVxlJA</id>
    <link href="https://mp.weixin.qq.com/s/LA47_Gtd5TnKxclooVxlJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山东新华健康科技有限公司创立大会暨互联网+医疗健康论坛隆重召开</title>
    <updated>2020-12-14T18:50:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Srp_pX1eed87f-3OB0m3nw</id>
    <link href="https://mp.weixin.qq.com/s/Srp_pX1eed87f-3OB0m3nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>倒计时2天！CPhI China闪“药”登场，制药工业实力引燃申城</title>
    <updated>2020-12-14T18:50:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/WWuMy06n7Ai0pb1h4CE6gA</id>
    <link href="https://mp.weixin.qq.com/s/WWuMy06n7Ai0pb1h4CE6gA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1/L1价格战一触即发！“以价换量”行不行？增量在哪？</title>
    <updated>2020-12-13T16:57:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/kfahSIkJ-az6UXVQyfFN7A</id>
    <link href="https://mp.weixin.qq.com/s/kfahSIkJ-az6UXVQyfFN7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药代备案制落地后首个被罚案例传出，涉知名外企！第四批国采今起报量！</title>
    <updated>2020-12-12T17:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/n108UCaFullN8W26RKvSUw</id>
    <link href="https://mp.weixin.qq.com/s/n108UCaFullN8W26RKvSUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床研究稽查避重就轻，水平越低越受欢迎？</title>
    <updated>2020-12-12T17:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/ygmmB_fBHJ0ibyXpPkb3-A</id>
    <link href="https://mp.weixin.qq.com/s/ygmmB_fBHJ0ibyXpPkb3-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>白云山金戈获评“十三五”中国医药科技标志性成果</title>
    <updated>2020-12-12T17:06:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/g3J7k_yAF2sclrnKj1oveA</id>
    <link href="https://mp.weixin.qq.com/s/g3J7k_yAF2sclrnKj1oveA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>原料药企收3亿罚单后，5家制剂企业开始降价！</title>
    <updated>2020-12-11T20:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Nuby0_bsIXke2GcR-IhOxg</id>
    <link href="https://mp.weixin.qq.com/s/Nuby0_bsIXke2GcR-IhOxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注黑色素瘤中西方差异，提升免疫创新疗法可及性</title>
    <updated>2020-12-11T20:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/_2qiGqtyT5ItmmGWUoOTvg</id>
    <link href="https://mp.weixin.qq.com/s/_2qiGqtyT5ItmmGWUoOTvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“十三五”医药产业成果巡礼隆重启幕，连花清瘟占据C位</title>
    <updated>2020-12-11T20:38:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/WcsoNcQjW3WIlB8bY61HeQ</id>
    <link href="https://mp.weixin.qq.com/s/WcsoNcQjW3WIlB8bY61HeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>